Cargando…
Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire––a DCCSS LATER study
BACKGROUND: Fatigue is often reported by patients with childhood cancer both during and after cancer treatment. Several instruments to measure fatigue exist, although none are specifically validated for use in childhood cancer survivors (CCS). The aim of the current study was to present norm values...
Autores principales: | Penson, Adriaan, Walraven, Iris, Bronkhorst, Ewald, Grootenhuis, Martha A., Tissing, Wim J. E., van der Pal, Helena J. H., de Vries, Andrica C. H., van den Heuvel‐Eibrink, Marry M., Neggers, Sebastian, Versluys, Birgitta A. B., Louwerens, Marloes, Pluijm, Saskia M. F., Blijlevens, Nicole, van der Heiden‐van der Loo, Margriet, Kremer, Leontien C. M., van Dulmen‐den Broeder, Eline, Knoop, Hans, Loonen, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855897/ https://www.ncbi.nlm.nih.gov/pubmed/34953059 http://dx.doi.org/10.1002/cam4.4490 |
Ejemplares similares
-
The Impact of Cancer-Related Fatigue on HRQOL in Survivors of Childhood Cancer: A DCCSS LATER Study
por: Penson, Adriaan, et al.
Publicado: (2022) -
Methodology of the DCCSS later fatigue study: a model to investigate chronic fatigue in long-term survivors of childhood cancer
por: Penson, Adriaan, et al.
Publicado: (2021) -
Prevalence and risk factors of cancer‐related fatigue in childhood cancer survivors: A DCCSS LATER study
por: van Deuren, Sylvia, et al.
Publicado: (2021) -
Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study
por: Kooijmans, Esmee C. M., et al.
Publicado: (2022) -
The Value of IgM Memory B-Cells in the Assessment of Splenic Function in Childhood Cancer Survivors at Risk for Splenic Dysfunction: A DCCSS-LATER Study
por: Houtman, Bente M., et al.
Publicado: (2023)